Middle East and Africa Point-of-Care Diagnostics Market is expected to grow with the CAGR of 6.1% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.
Access Full Report @ https://www.databridgemarketresearch.com/reports/middle-east-and-africa-point-of-care-diagnostics-market
Middle East and Africa point-of-care diagnostics market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in Middle East and Africa point-of-care diagnostics market are introducing strong range of point-of-care diagnostics’ products provider along with launching new point-of-care diagnostics’ products and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.
For instance:
- In August 2020, Siemens Healthcare S.A.E. (a subsidiary of Siemens Healthineers AG) has announced that they have agreed to the acquisition of the company named Varian to enhance the fight against cancer and for strengthening their business in the healthcare sector. It will help the company in the enhancement of its credibility in the market.
F. Hoffmann-La Roche Ltd is the dominating player in Middle East and Africa Point-of-care diagnostics market. The other key players existing in the market are Quidel Corporation, BD, Sekisui Diagnostics, BioTech Africa, Medtronic, Bio-Rad Laboratories, Inc., PTS Diagnostics, Trinity Biotech, Atlas Medical UK, Abbott, bioMérieux SA, Sysmex Corporation, Siemens Healthcare S.A.E. (a subsidiary of Siemens Healthineers AG), Instrumentation Laboratory (A subsidiary of Werfen), Nova Biomedical, ACON Laboratories, Inc. and URIT MEDICAL ELECTRONIC CO., LTD. among others.
F. Hoffmann-La Roche Ltd
F. Hoffmann-La Roche Ltd headquartered in Basel, Switzerland. F. Hoffmann-La Roche Ltd, founded in the year 1896. The company is engaged in creating innovative medicines and diagnostics tests that help millions of people worldwide. The company has product categories which are Pharmaceuticals, Solutions for Diagnostics, Products for Researchers in which Solutions for Diagnostics is the market focused categories.
- In June 2014, F. Hoffmann-La Roche Ltd had launched a fully automated urine testing analyzer which can process more than one thousand urine samples per day. The major goal of the company is to focus on the development of digital examination in testing and to provide higher quality solutions to the laboratories. This launch helped the company to broaden its product portfolio of urinalysis.
The company has presence across North America, Europe, Africa, Asia and Oceania. The company also has various subsidiary companies such as Roche Diagnostica Brasil Ltda. (Brazil), Roche Diabetes Care Brasil Ltda. (Brazil), Trophos SA (France), INSTITUT ROCHE SAS (France) and Roche Diagnostics K.K. (Japan) among more.
Siemens Healthcare S.A.E. (a subsidiary of Siemens Healthineers AG)
Siemens Healthcare S.A.E. (a subsidiary of Siemens Healthineers AG) headquartered in Munich, Germany. Siemens Healthcare S.A.E. (a subsidiary of Siemens Healthineers AG) is founded in the year 1896. The company focuses on intelligent infrastructure for buildings and decentralized energy systems, on automation and digitalization in the process and manufacturing industries, and on smart mobility solutions for rail and road transport. The company has various product categories that are Value Partnership and Consulting, Medical Imaging, Laboratory Diagnostics, Point-of–Care-Testing, Services, Clinical Specialties, Accessories, OEMs & Electronics, Healthcare IT in which Point-of–Care-Testing is the market focused category.
- In February 2021, Siemens Healthcare S.A.E. (a subsidiary of Siemens Healthineers AG) signed an agreement with Sysmex Corporation. The agreement includes distribution and sales of Sysmex Corporation’s Sysmex CN blood coagulation systems. With the help of the agreement both the companies will be able to provide their homeostasis product portfolio. This will help the growth of the market in coming years.
The company has presence in Asia-Pacific, Europe, Middle-East and South Africa, The Americas.
Beckman Coulter, Inc.
Beckman Coulter, Inc. headquartered in Pasadena, U.S. Beckman Coulter, Inc., founded in the year 1935. The company develops, manufactures the markets products that simplify automate and innovate complex biological testing. The company has product categories such as Chemistry, Immunoassays, Hematology, Urinalysis, Microbiology, Blood Banking, and Protein Chemistry in which Urinalysis is the market focused category.
For instance,
- In May 2019, Beckman Coulter, Inc introduced a total laboratory automation solution having a new standard for turnaround time. This automation solution services will help in getting good quality results and will improve laboratory operations. This will help the company in setting a new standard of quality services and hence will help in generating more revenue in the future.
The company has wide presence across North America, South America, Europe, Middle East & Africa and Asia Pacific. The company also has various subsidiary companies such as Labcyte Inc (U.S.), Beckman Coulter K.K. (U.S.), Beckman Coulter international S.A. (South America) and Beckman coulter Eurocenter S.A. (U.S.) among others.
